Ananda K. Kanduluru - Publications
Affiliations: | 2016- | On Target Laboratory |
Year | Citation | Score | |||
---|---|---|---|---|---|
2019 | Kanduluru AK, Srinivasarao M, Wayua C, Low PS. Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 31292915 DOI: 10.1007/S11307-019-01391-W | 0.386 | |||
2018 | Lee YG, Marks I, Srinivasarao M, Kanduluru AK, Mahalingam SM, Liu X, Chu H, Low PS. Use of a single CAR T cell and several bispecific adapters facilitates eradication of multiple antigenically different solid tumors. Cancer Research. PMID 30482775 DOI: 10.1158/0008-5472.Can-18-1834 | 0.361 | |||
2018 | Zhang H, Kanduluru AK, Desai P, Ahad A, Carlin SD, Tandon N, Weber W, Low PS. Synthesis and evaluation of a novelCu/Ga-labeled neurokinin 1 receptor antagonist for in vivo targeting of NK1R-positive tumor xenografts. Bioconjugate Chemistry. PMID 29466853 DOI: 10.1021/Acs.Bioconjchem.8B00063 | 0.349 | |||
2017 | Kanduluru AK, Low PS. Development of a Ligand-Targeted Therapeutic Agent for Neurokinin-1 Receptor Expressing Cancers. Molecular Pharmaceutics. PMID 28969417 DOI: 10.1021/Acs.Molpharmaceut.7B00583 | 0.422 | |||
2016 | Kanduluru AK, Srinivasarao M, Low PS. Design, Synthesis and Evaluation of a Neurokinin 1 Receptor-Targeted Near IR Dye for Fluorescence Guided Surgery of Neuroendocrine Cancers. Bioconjugate Chemistry. PMID 27529726 DOI: 10.1021/Acs.Bioconjchem.6B00374 | 0.573 | |||
2015 | Roy J, Nguyen TX, Kanduluru AK, Venkatesh C, Lv W, Reddy PV, Low PS, Cushman M. DUPA conjugation of a cytotoxic indenoisoquinoline topoisomerase I inhibitor for selective prostate cancer cell targeting. Journal of Medicinal Chemistry. 58: 3094-103. PMID 25822623 DOI: 10.1021/Jm5018384 | 0.563 | |||
Show low-probability matches. |